Role of pharmacologically active metabolites in drug discovery and development

Drug Discovery Today
Aberra Fura

Abstract

Pharmacologically active metabolites can contribute significantly to the overall therapeutic and adverse effects of drugs. Therefore, to fully understand the mechanism of action of drugs, it is important to recognize the role of active metabolites. Active metabolites can also be developed as drugs in their own right. Using illustrative examples, this paper discusses a variety of biotransformation reactions that produce active metabolites and their structure-activity relationships. The paper also describes the role and significance of active metabolites in drug discovery and development, various experimental observations that can be used as indicators of their presence, and methods that can be used to assess their biological activities and contribution to the overall therapeutic and adverse effects of drugs.

References

Mar 1, 1987·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R M WelchD H Schroeder
Dec 15, 1985·International Journal of Cancer. Journal International Du Cancer·R LöserU Eppenberger
Jul 1, 1983·Biochemical Pharmacology·J V KempR Slater
Mar 24, 1993·JAMA : the Journal of the American Medical Association·P K HonigL R Cantilena
Mar 1, 1993·Journal of Pharmaceutical Sciences·B V GalloD J Weidler
Dec 1, 1995·Clinical Pharmacokinetics·F Kamali, C Edwards
Jun 1, 1997·British Journal of Clinical Pharmacology·J K CollerF Bochner
May 5, 1998·Chemico-biological Interactions·R J AndersonD L Clemens
Dec 16, 1998·Therapeutic Drug Monitoring·J M Potter, A Donnelly
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A G Renwick
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R E White
Aug 15, 2000·Therapeutic Drug Monitoring·A LlerenaJ Benítez
Jun 21, 2001·Chemical Research in Toxicology·F P Guengerich
Oct 2, 2001·Medicinal Research Reviews·G N Kumar, S Surapaneni
Feb 5, 2002·Clinical Pharmacokinetics·Jorn LotschGerd Geisslinger
Mar 2, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Susan Rotzinger, Glen B Baker
May 31, 2002·Clinical Pharmacokinetics·David Williams, John Feely
Apr 30, 2003·Journal of Mass Spectrometry : JMS·R KostiainenS Auriola
Jul 10, 2003·British Journal of Clinical Pharmacology·Thomayant PrueksaritanontNathan Yu
Jul 18, 2003·Drug Discovery Today·Olivia Corcoran, Manfred Spraul
Sep 23, 2003·Journal of Pharmaceutical Sciences·Joseph W PolliCosette J Serabjit-Singh
Oct 8, 2003·The Journal of Allergy and Clinical Immunology·Suzanne G Meeves, Sireesh Appajosyula
Oct 9, 2003·Clinical Pharmacokinetics·Hans Lennernäs
Jan 28, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ying-Hong WangStephen D Hall
Apr 28, 2004·Breast Cancer Research and Treatment·Michael D JohnsonTodd C Skaar
May 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Zeruesenay DestaDavid A Flockhart
Aug 20, 2004·Journal of Medicinal Chemistry·Aberra FuraW Griffith Humphreys
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·B Kevin ParkDominic P Williams
May 3, 2005·The American Journal of Psychiatry·Rikus KnegteringRobert J van den Bosch
May 21, 2005·The American Journal of Geriatric Pharmacotherapy·Barry J Cusack
Jul 2, 2005·Critical Reviews in Toxicology·Jennie L WalgrenDavid C Thompson

❮ Previous
Next ❯

Citations

Apr 8, 2010·Pharmaceutical Research·Yin Cheong Wong, Zhong Zuo
Feb 22, 2012·Journal of the American Society for Mass Spectrometry·Robert ChoJi Ma
Mar 17, 2009·Bioinformatics·Mingyue ZhengHualiang Jiang
Oct 12, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Myung Joo KangJaehwi Lee
May 3, 2011·Drug Metabolism and Pharmacokinetics·Takashi Izumi
Dec 14, 2012·Future Medicinal Chemistry·Nyaradzo T L Chigorimbo-MurefuKelly Chibale
Nov 1, 2010·Therapeutic Delivery·John WatkinsDonald R J Singer
Jan 13, 2016·Analytical and Bioanalytical Chemistry·Jelle ReinenMaarten Honing
Mar 19, 2013·Drug Discovery Today·Göran Dahl, Tomas Akerud
Jan 7, 2016·Frontiers in Microbiology·Luiz F BianchiniEdvaldo A R Rosa
Nov 26, 2009·Bioorganic & Medicinal Chemistry Letters·C LunnissN Trivedi
Jan 11, 2014·Expert Opinion on Therapeutic Patents·Ahmed KamalMohammed Shaheer Malik
Apr 7, 2010·Expert Opinion on Drug Metabolism & Toxicology·Shibashish GiriAugustinus Bader
May 15, 2010·Expert Opinion on Drug Metabolism & Toxicology·Anthony E Klon
Mar 10, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hoa Q NguyenR Scott Obach
Jun 25, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Ibrahim AlhaiderB M Gupta
Feb 7, 2015·Bioorganic & Medicinal Chemistry Letters·Núbia C de PaulaValéria de Oliveira
Apr 23, 2013·Chemistry & Biology·Miquel Duran-Frigola, Patrick Aloy
May 26, 2016·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Mareike GlockJohannes Kornhuber
Jun 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Iain J MartinErin F Mulrooney
Sep 15, 2018·Expert Opinion on Drug Metabolism & Toxicology·Chunyong He, Hong Wan
Nov 23, 2018·Expert Opinion on Drug Metabolism & Toxicology·Martyn HowardAmin Rostami-Hodjegan
Mar 5, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cho-Ming LoiDeepak Dalvie
Apr 5, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Deepak K LokwaniJulio A Seijas
Jun 23, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·S M van LiempdN P E Vermeulen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.